Advanced Search
Contact | Corporate | Help

Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer

Sponsors:
  • Massachusetts General Hospital
  • Beth Israel Deaconess Medical Center
  • Dana-Farber Cancer Institute
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Rectal Cancer
  • Adenocarcinoma of the Rectum
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: 5-fluorouracil
  • Drug: bevacizumab
  • Drug: erlotinib
  • Procedure: External beam radiation therapy (EBRT)
Enrollment:
32

Additional information about NCT00307736.


SourceSolution © 2008-2012